IVD Medical : ANNOUNCEMENT PURSUANT TO RULES 13.51(2) AND 13.51B(2) OF THE LISTING RULES

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

IVD Medical Holding Limited

華 檢 醫 療 控 股 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1931)

ANNOUNCEMENT PURSUANT TO RULES 13.51(2) AND

13.51B(2) OF THE LISTING RULES

This announcement is made by IVD Medical Holding Limited (the "Company") pursuant to Rules 13.51(2) and 13.51B(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. Reference is made to the announcement of the Company dated 4 November 2019.

On 12 May 2021, the Securities and Futures Commission (the "SFC") issued a press release in relation to proceedings brought by the SFC before the Market Misconduct Tribunal against China Medical & HealthCare Group Limited, formerly known as COL Capital Limited ("COL"), a company listed on the Main Board of The Stock Exchange of Hong Kong Limited (Stock Code:

1. and six of its former and current directors for failing to disclose inside information as soon as reasonably practicable.

Mr. Lau Siu Ki ("Mr. Lau"), an independent non-executive director of the Company, was a former independent non-executive director of COL. Mr. Lau admitted to the Market Misconduct Tribunal that his negligent conduct had resulted in COL's breach of the requirements of the corporate disclosure regime.

The Market Misconduct Tribunal ordered, among other matters, that:

1. Mr. Lau, COL and the other five former and current directors of COL to pay the SFC's investigation and legal costs, as well as the costs of the Market Misconduct Tribunal proceedings;
2. Mr. Lau was fined HK$300,000; and
3. Mr. Lau attends an SFC-approved training programme on the corporate disclosure regime, directors' duties and corporate governance.

1

As the orders made by the Market Misconduct Tribunal do not involve the Company or any of its subsidiaries (collectively, the "Group"), the Company does not consider that such orders will have any material adverse impact on the businesses and/or operations of the Group.

By order of the Board of

IVD Medical Holding Limited

Ho Kuk Sing

Chairman and Executive Director

Hong Kong, 12 May 2021

As at the date of this announcement, the Board comprises three executive directors, namely, Mr. Ho Kuk Sing, Mr. Leung King Sun and Mr. Lin Xianya, three non-executive directors, namely, Mr. Chen Xingang, Mr. Yang Zhaoxu and Mr. Chan Kwok King, Kingsley and three independent non- executive directors, namely, Mr. Lau Siu Ki, Mr. Zhong Renqian and Mr. Leung Ka Sing.

2